logo
Risk scores in acute coronary syndrome and percutaneous coronary intervention: A review
Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review
Obstructive sleep apnea and cardiovascular disease in blacks: A call to action from the Association of Black Cardiologists
Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium
The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development
Telemedicine cardiovascular risk reduction in Veterans
Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study
Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis
The PARACHUTE IV trial design and rationale: Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles
Sex-related effectiveness of bivalirudin versus abciximab and heparin in non–ST-segment elevation myocardial infarction
The association of fetal cerebrovascular resistance with early neurodevelopment in single ventricle congenital heart disease
Relation of right ventricular mechanics to exercise tolerance in children after tetralogy of Fallot repair
Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy
Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation
Iron deficiency in chronic heart failure: An international pooled analysis
Radial versus femoral access, bleeding and ischemic events in patients with non–ST-segment elevation acute coronary syndrome managed with an invasive strategy
Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularization
Use of the contrast volume or grams of iodine–to–creatinine clearance ratio to predict mortality after percutaneous coronary intervention
Discordant effects of rosiglitazone on novel inflammatory biomarkers
Managing hypertension in urban underserved subjects using telemedicine—A clinical trial
Rate versus rhythm control for management of atrial fibrillation in clinical practice: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: One-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study
Correction
Correction
Global cardiovascular clinical trials and geographic altitude
Response to “Global cardiovascular clinical trials and geographic altitude”
The prognostic implication of high-sensitivity C-reactive protein in patients with established cardiomyopathy
Response to “The prognostic implication of high-sensitivity C-reactive protein in patients with established cardiomyopathy”